ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.72% | -15.53% | -10.99% | -7.60% | -16.70% |
| Total Depreciation and Amortization | -13.20% | -13.01% | -3.75% | -6.69% | -172.89% |
| Total Amortization of Deferred Charges | 4.94% | 4.77% | -- | -- | 132.16% |
| Total Other Non-Cash Items | -- | -- | 43.14% | 38.77% | 100.00% |
| Change in Net Operating Assets | -154.13% | -154.04% | -- | -- | 171.04% |
| Cash from Operations | -31.96% | -31.74% | -10.34% | -6.97% | 30.76% |
| Capital Expenditure | -23.96% | -23.94% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -479.86% | -479.21% | 86.13% | 86.48% | 109.36% |
| Cash from Investing | -866.80% | -864.90% | 86.13% | 86.48% | 105.29% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -2,466.00% | -2,466.00% | 22.07% | 22.07% | 16.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -68.73% | -68.73% | -- | -- | -- |
| Cash from Financing | -44.39% | -44.48% | 2,847.03% | 2,761.02% | 5,713.91% |
| Foreign Exchange rate Adjustments | 56.10% | 56.18% | -175.56% | -173.27% | -476.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.90% | -187.75% | 51.57% | 53.06% | 135.56% |